Tetraphase Pharmaceuticals, Inc
16 clinical trials · Sponsor
◉ Watch Tetraphase Pharmaceuticals, Inc
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI) (NCT06794541) | Tetraphase Pharmaceuticals, Inc | 2025-05-22 |
| A Safety and PK Study of IV Eravacycline (NCT03696550) | Tetraphase Pharmaceuticals, Inc | 2018-12-20 |
| A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study (NCT03450187) | Tetraphase Pharmaceuticals, Inc | 2018-03-20 |
Track Tetraphase Pharmaceuticals, Inc automatically
Every clearance here is in the API, with alerts when new ones post.